Vertex Pharmaceuticals (NASDAQ: VRTX) and AstraZeneca (NASDAQ: AZN), two of the world's leading drugmakers, missed last ...

Vistagen Therapeutics, Inc.'s fasedienol shows promise in treating social anxiety; new results expected 2025. Click for my ...

Agoura Hills-based biotech firm Acelyrin Inc. agreed to merge with San Francisco-based Alumis Inc. in a deal valued at $320 ...

Healthcare isn't the hottest sector these days. While the S&P 500 has soared nearly 21% over the last 12 months, healthcare ...

Relay Therapeutics' financial stability is strong, but zero Q3 2024 revenue and rising net losses raise concerns. Find out ...

Encoded’s layoffs will mostly affect its technology and early-stage research and development functions. The move is expected ...

A look at the M&A and stock market pictures for full-year 2024—and the potential strategic implications for pharma and ...

CRISPR Therapeutics AG (CRSP) stock jumped over 9% this week after delivering strong Q4 2024 results ahead of schedule. The ...

If Portage is not in compliance with the continued listing standards by June 9, 2025, or if Portage does not make progress ...

Astellas has invested heavily in novel technologies that are not necessarily the most successful or popular in the industry.